Status:
UNKNOWN
Improvement of Pigmented Skin Lesions in Patients With Mastocytosis After Performing 2 Sessions of Pigment Laser
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Cutaneous Mastocytosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cutaneous mastocytosis can be isolated or associated with systemic involvement. Urticaria pigmentosa affects around 80 to 85% of adult patients with cutaneous mastocytosis. It is also frequently prese...
Detailed Description
Cutaneous mastocytosis can be isolated or associated with systemic involvement. Urticaria pigmentosa affects around 80 to 85% of adult patients with cutaneous mastocytosis. It is also very frequently ...
Eligibility Criteria
Inclusion
- Patient with mastocytosis (diagnosis confirmed clinically according to international criteria)
- Patient with pigmented skin lesions, of moderate to very severe severity (by comparison with a 4-point photographic scale: light, moderate, severe and very severe)
- Major patient aged ≥ 18 years.
- Patient with social security coverage
- Patient having given written, free and informed consent to participate in the study
Exclusion
- Patients with mastocytosis, without skin lesions
- Patient with pigmented skin lesions, only of mild severity (by comparison with a 4-point photographic scale: mild, moderate, severe and very severe)
- Patient with another cutaneous mastocytosis phenotype
- Patient treated by a treatment known as a cytoreductive for mastocytosis: alpha interferon, cladribine, imatinib, midostaurin or any cytoreductive treatment being evaluated by clinical trial in mastocytosis
- Patient under guardianship, or under curatorship, or not fluent in the French language or unable to understand and complete the study questionnaires
- pregnant or breastfeeding women
- Patients with tanned skin following photoexposure within 3 weeks of starting the study
Key Trial Info
Start Date :
September 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04377828
Start Date
September 14 2020
End Date
June 1 2022
Last Update
September 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Larrey Hospital - Toulouse University Hospital
Toulouse, France, 31059